These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 25524559)

  • 1. Improving recognition and referral of patients with an increased familial risk of colorectal cancer: results from a randomized controlled trial.
    Dekker N; Hermens RP; de Wilt JH; van Zelst-Stams WA; Hoogerbrugge N;
    Colorectal Dis; 2015 Jun; 17(6):499-510. PubMed ID: 25524559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial colorectal cancer risk assessment needs improvement for more effective cancer prevention in relatives.
    Dekker N; Hermens RP; Nagengast FM; van Zelst-Stams WA; Hoogerbrugge N;
    Colorectal Dis; 2013 Apr; 15(4):e175-85; discussion p.e185. PubMed ID: 23451840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Easy-to-use online referral test detects most patients with a high familial risk of colorectal cancer.
    Dekker N; Hermens RP; Mensenkamp AR; van Zelst-Stams WA; Hoogerbrugge N
    Colorectal Dis; 2014 Jan; 16(1):O26-34. PubMed ID: 24034789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High uptake of colonoscopy in first-degree relatives of patients with colorectal cancer in a healthcare region: a population-based, prospective study.
    Armelao F; Orlandi PG; Tasini E; Franceschini G; Franch R; Paternolli C; de Pretis G
    Endoscopy; 2010 Jan; 42(1):15-21. PubMed ID: 20066589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of family history of colorectal cancer in primary care: perceptions of first degree relatives of people with colorectal cancer.
    Cameron E; Rose S; Carey M
    Patient Educ Couns; 2014 Mar; 94(3):427-31. PubMed ID: 24380670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving calculation, interpretation and communication of familial colorectal cancer risk: protocol for a randomized controlled trial.
    Dekker N; Hermens RP; Elwyn G; van der Weijden T; Nagengast FM; van Duijvendijk P; Salemink S; Adang E; van Krieken JH; Ligtenberg MJ; Hoogerbrugge N
    Implement Sci; 2010 Jan; 5():6. PubMed ID: 20181032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of indicators to evaluate colorectal cancer prevention programs in the high-risk population: the experience of a high-risk colorectal cancer clinic].
    Serra Sutton V; Espallargues M; Balaguer F; Castells A
    Gastroenterol Hepatol; 2012 Nov; 35(9):613-24. PubMed ID: 22749512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased risk of colorectal neoplasia among family members of patients with colorectal cancer: a population-based study in Utah.
    Samadder NJ; Curtin K; Tuohy TM; Rowe KG; Mineau GP; Smith KR; Pimentel R; Wong J; Boucher K; Burt RW
    Gastroenterology; 2014 Oct; 147(4):814-821.e5; quiz e15-6. PubMed ID: 25042087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colonoscopy surveillance of individuals at risk of familial colorectal cancer.
    Bradshaw N; Holloway S; Penman I; Dunlop MG; Porteous ME
    Gut; 2003 Dec; 52(12):1748-51. PubMed ID: 14633955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.
    Quintero E; Carrillo M; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Díez-Fuentes ML; Abraira V
    Gastroenterology; 2014 Nov; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of an online questionnaire for identifying people at risk of familial and hereditary colorectal cancer.
    Kallenberg FG; IJspeert JE; Bossuyt PM; Aalfs CM; Dekker E
    Fam Cancer; 2015 Sep; 14(3):401-10. PubMed ID: 25800523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Family history and colorectal cancer screening: a survey of physician knowledge and practice patterns.
    Schroy PC; Barrison AF; Ling BS; Wilson S; Geller AC
    Am J Gastroenterol; 2002 Apr; 97(4):1031-6. PubMed ID: 12008667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychosocial impact of the lack of information given at referral about familial risk for cancer.
    Metcalfe A; Werrett J; Burgess L; Clifford C
    Psychooncology; 2007 May; 16(5):458-65. PubMed ID: 16933207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inadequate screening and low awareness about risk factors among first-degree relatives of colorectal cancer patients].
    Vítek P; Kajzrlíková IM; Bures J; Chalupa J
    Vnitr Lek; 2011 Dec; 57(12):1057-61. PubMed ID: 22277042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of database linkage: are patients at risk of familial colorectal cancer being referred for genetic counselling and testing?
    Wong C; Gibbs P; Johns J; Jones I; Faragher I; Lynch E; Macrae F; Lipton L
    Intern Med J; 2008 May; 38(5):328-33. PubMed ID: 17916174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colonoscopic screening of asymptomatic first-degree relatives of colorectal cancer patients.
    Croitoru L; Trifan A; Maxim MR; Girleanu I; Hulub A; Dimache M; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(3):683-6. PubMed ID: 21235115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of patients at increased risk for colorectal cancer in an open access endoscopy center.
    Nathanson JW; Zisman TL; Julian C; McCaffrey S; Rubin DT
    J Clin Gastroenterol; 2008 Oct; 42(9):1025-31. PubMed ID: 18719509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gatekeeper role of gastroenterologists and surgeons in recognising and discussing familial colorectal cancer.
    Douma KF; Dekker E; Smets EM; Aalfs CM
    Fam Cancer; 2016 Apr; 15(2):231-40. PubMed ID: 26687117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening.
    Dekker N; van Rossum LG; Van Vugt-van Pinxteren M; van Stiphout SH; Hermens RP; van Zelst-Stams WA; van Oijen MG; Laheij RJ; Jansen JB; Hoogerbrugge N
    Eur J Cancer; 2011 Jul; 47(10):1571-7. PubMed ID: 21367600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory bowel disease cancer surveillance in a tertiary referral hospital: attitudes and practice.
    Verschuren EC; Ong DE; Kamm MA; Desmond PV; Lust M
    Intern Med J; 2014 Jan; 44(1):40-9. PubMed ID: 24015799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.